Particle.news
Business ❯ Finance ❯ Investment
Corporate Strategy Stake Acquisition Cross-Border Transactions Strategic Partnerships Takeover Bids Corporate Governance Corporate Transactions Banamex Takeover Special Purpose Acquisition Companies Private Equity Takeover Offers Banca Generali Market Expansion Public Offerings Mediobanca Paramount Global Grupo México Stakeholders Market Dynamics Media Acquisitions Valuation Takeover Talks Buyout Deals Port Operations Abu Dhabi Arrangement Hut 8 and US Bitcoin Corp Merger Comcast Prospects Delivery Market Delivery Hero SPAC Game Studio Jagex Controlling Stake Blank-Check Company Planned Merger Company Valuation Company Sale Stock Market Deal Negotiation Mining Industry Acquisition Strategy Takeover Bid Regional Players Strategic Integration Kotak Mahindra Bank Morgan Stanley Afterpay Commercial Loans Private Banks Industrial Gas Takeovers Corporate Acquisitions IPO Activities Acquisition Strategies Carrefour Argentina Crypto Industry Shareholding Market Strategy YPF and Vista Energy Idox Tender Offers Wincanton Acquisition Privatization Proposals Vector Casa de Bolsa Strategic Acquisitions Market Control Market Impact Corporate Integration Joint Ventures BBVA Offer Stake Sales Goldman Sachs Acquisitions Alsea PC Financial Sports Investments Trust Mergers Akero Therapeutics Deal Value Bank Sales SPAC Transactions Company Sales Startup Valuation UBS BB Investment Bank Bharti Airtel Market Reactions Privatisation Regional M&A Funds Industry Consolidation Large Deals Stake Purchases Banking Corporate Sales Eastern Michigan Financial Corporation Corporate Offers CrownRock Acquisition Tilray Brands Valuation and Revenue
The deal would bring Halda’s RIPTAC technology plus prostate cancer pill HLD-0915 under J&J pending antitrust clearance.
